us cms reimbursement $86.59 Just announced.
Cellestis Limited advises that the US Clinical Lab Fee Schedule for 2006 published by the Centers for Medicare and Medicaid Services (CMS) has incorporated QuantiFERON®-TB Gold and defined an acceptable fee for providing this test. The fee is set at USD$86.59 per test performed in all States of America except Rhode Island, Indiana, Vermont and parts of New York, where the reimbursement amount is less.
Another giant leap forward for Cellestis.
- Forums
- ASX - By Stock
- qft-g needed!
us cms reimbursement $86.59 Just announced.Cellestis Limited...
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CST (ASX) to my watchlist